Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adherence and pharmacokinetics of erlotinib in NSCLC routine practice
NL-OMON33122Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Vrije University Medical Center. Primary endpoints: Adherence rate, Plasma concentration of erlotinib and 1 more. Started Oct 2009; status: active, not recruiting.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON33122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33122.